Big Gain For Acurx Pharmaceuticals, Inc.
Tue, Jun 17, 2025 at 07:10 PM
Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ) soared at $0.82, a gain of 167.2%. On Tue, Jun 17, 2025, ACXP:NASDAQ hit a New 2-Week High of $0.82. The stock appeared on our News Catalysts scanner on Tue, Jun 17, 2025 at 09:06 AM in the 'BIOTECH' category. From Tue, Jun 03, 2025, the stock recorded 30.00% Up Days and 9.09% Green Days
The stock spiked on Tue, Jun 17, 2025 at $1.05 with a volume of 340M+.
About Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ)
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health...
Top 10 Gainers:
- CERo Therapeutics Holdings, Inc. (CERO:NASDAQ), 188.73%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 167.24%
- Eyenovia, Inc. (EYEN:NASDAQ), 134.68%
- Robin Energy Ltd. (RBNE:NASDAQ), 91.85%
- Houston American Energy Corp. (HUSA:NYSEMKT), 88.68%
- Verve Therapeutics, Inc. (VERV:NASDAQ), 81.5%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 66.53%
- Galectin Therapeutics Inc. (GALT:NASDAQ), 60.4%
- Beyond Air, Inc. (XAIR:NASDAQ), 58.69%
- Digital Turbine, Inc. (APPS:NASDAQ), 56.76%